{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:09:18Z","timestamp":1792066158835,"version":"4.4.0"},"reference-count":27,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM-DQ20170336751"],"award-info":[{"award-number":["FRM-DQ20170336751"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-14-CE15-0001-MECANO"],"award-info":[{"award-number":["ANR-14-CE15-0001-MECANO"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012-BETPSY"],"award-info":[{"award-number":["ANR-18-RHUS-0012-BETPSY"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundacion Alfonso Martin Escudero"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,5,11]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Antibodies against contactin-associated protein-like 2 (CASPR2-Abs) have been described in acquired neuromyotonia, limbic encephalitis (LE) and Morvan syndrome (MoS). However, it is unknown whether these constitute one sole spectrum of diseases with the same immunopathogenesis or three distinct entities with different mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cluster analysis of neurological symptoms was performed in a retrospective cohort of 56 CASPR2-Abs patients. In parallel, immunological features and human leucocyte antigen (HLA) were studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Cluster analysis distinguished patients with predominant limbic symptoms (n=29\/56) from those with peripheral nerve hyperexcitability (PNH; n=27\/56). In the limbic-prominent group, limbic features were either isolated (LE\/\u2212; 18\/56, 32.1%), or combined with extralimbic symptoms (LE\/+; 11\/56, 19.6%). Those with PNH were separated in one group with severe PNH and extralimbic involvement (PNH\/+; 16\/56, 28.6%), resembling historical MoS descriptions; and one group with milder and usually isolated PNH (PNH\/\u2212; 11\/56, 19.6%). LE\/\u2212 and LE\/+ patients shared immunogenetic characteristics demonstrating a homogeneous entity. HLA-DRB1*11:01 was carried more frequently than in healthy controls only by patients with LE (94.1% vs 18.3%; p=1.3\u00d710\n                      <jats:sup>\u221210<\/jats:sup>\n                      ). Patients with LE also had serum titres (median 1:40 960) and rates of cerebrospinal fluid positivity (93.1%) higher than the other groups (p&lt;0.05). Conversely, DRB1*11:01 association was absent in PNH\/+ patients, but only they had malignant thymoma (87.5%), serum antibodies against leucine-rich glioma-inactivated 1 protein (66.7%) and against netrin-1 receptor deleted in colorectal carcinoma (53.8%), and myasthenia gravis (50.0%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Symptoms\u2019 distribution supports specific clinical phenotypes without overlap between LE and MoS. The distinct immunogenetic characteristics shared by all patients with LE and the particular oncological and autoimmune associations of MoS suggest two very different aetiopathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2020-323226","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T17:24:55Z","timestamp":1594401895000},"page":"1076-1084","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":107,"title":["Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features"],"prefix":"10.1136","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3288","authenticated-orcid":false,"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mad-H\u00e9l\u00e9nie","family":"Elsensohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laurie","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Saint-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-7061","authenticated-orcid":false,"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Maucort-Boulch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"2024111108050904000_91.10.1076.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213"},{"key":"2024111108050904000_91.10.1076.2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22297"},{"key":"2024111108050904000_91.10.1076.3","first-page":"164","article-title":"La chor\u00e9e fibrillaire de Morvan bilan de 70 observations dont 30 personnelles","volume":"88","author":"Roger","year":"1953","journal-title":"Revue Neurologique"},{"key":"2024111108050904000_91.10.1076.4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23577"},{"key":"2024111108050904000_91.10.1076.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002917"},{"key":"2024111108050904000_91.10.1076.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24979"},{"key":"2024111108050904000_91.10.1076.7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"2024111108050904000_91.10.1076.8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-194-3_5"},{"key":"2024111108050904000_91.10.1076.9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.1585","article-title":"Characterization of a subtype of autoimmune encephalitis with Anti-Contactin-Associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures","volume":"73","author":"Joubert","year":"2016","journal-title":"JAMA Neurol"},{"key":"2024111108050904000_91.10.1076.10","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww012"},{"key":"2024111108050904000_91.10.1076.11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-63"},{"key":"2024111108050904000_91.10.1076.12","doi-asserted-by":"publisher","DOI":"10.2307\/4615733"},{"key":"2024111108050904000_91.10.1076.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301506"},{"key":"2024111108050904000_91.10.1076.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.01.040"},{"key":"2024111108050904000_91.10.1076.15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000371"},{"key":"2024111108050904000_91.10.1076.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2681","article-title":"Association of leucine-rich glioma inactivated protein 1, Contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia","volume":"75","author":"Vincent","year":"2018","journal-title":"JAMA Neurol"},{"key":"2024111108050904000_91.10.1076.17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.12.2417"},{"key":"2024111108050904000_91.10.1076.18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.sleep.2011.08.006","article-title":"Video-Polysomnographic study of a patient with Morvan's fibrillary chorea","volume":"13","author":"Lanuzza","year":"2012","journal-title":"Sleep Med"},{"key":"2024111108050904000_91.10.1076.19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.sleep.2011.10.004","article-title":"Agrypnia excitata","volume":"12 Suppl 2","author":"Lugaresi","year":"2011","journal-title":"Sleep Med"},{"key":"2024111108050904000_91.10.1076.20","doi-asserted-by":"crossref","first-page":"102563","DOI":"10.1016\/j.autneu.2019.102563","article-title":"Obstructive sleep apnea syndrome and autonomic dysfunction","volume":"221","author":"Lombardi","year":"2019","journal-title":"Auton Neurosci"},{"key":"2024111108050904000_91.10.1076.21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"2024111108050904000_91.10.1076.22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2024111108050904000_91.10.1076.23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000127"},{"key":"2024111108050904000_91.10.1076.24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-Lgi1 encephalitis is associated with unique HLA subtypes: HLA subtypes in anti-LGI1 encephalitis","volume":"81","author":"Kim","year":"2017","journal-title":"Annals of Neurology"},{"key":"2024111108050904000_91.10.1076.25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-Lgi1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"2024111108050904000_91.10.1076.26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003778"},{"key":"2024111108050904000_91.10.1076.27","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf178"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-323226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T11:06:58Z","timestamp":1731323218000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-323226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,15]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/jnnp-2020-323226"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-323226","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}